After the recent launch of wellness brand SurvivorRx's supplement range for cancer survivors, NBR caught up with Dr Joe Mignone, Oncologist and Co-Founder of SurvivorRx to discuss the personalised product line, how it works and the science behind each formulation, as well as the growth of the personalised nutrition market.
This is a small extract of the full article which is available
ONLY to premium content subscribers.
Click below to get premium content on Nutraceutical Business Review.
Not yet a Subscriber?
Personalised supplements for cancer survivors: a gap in the market?
As the personalised nutrition trend grows in popularity, oncologist Dr Joe Mignone talks us through his first nutraceutical line designed specifically for cancer survivors
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You may also like
Trending Articles
You may also like
Distribution
![Hikma Ventures invests in Rem3dy Health to take 3D-printed supplements to seven MENA markets]()
Hikma Ventures invests in Rem3dy Health to take 3D-printed supplements to seven MENA markets
The undisclosed investment pairs Rem3dy’s seven-layer personalised gummy technology with Hikma’s regional distribution network, with launches planned in the UAE, Saudi Arabia and Jordan in Q1 2027
Dietary supplements
![More than a quarter of berberine supplements sold on Amazon fail to meet label claims]()
More than a quarter of berberine supplements sold on Amazon fail to meet label claims
The second investigation in Cata-Kor's independent testing series found seven out of twenty berberine supplements contained far less berberine than stated on their labels, with one product containing no detectable berberine at all
Digestion
![Biohm Technologies launches Ascomya fungal probiotic platform with first ingredient PK88]()
Biohm Technologies launches Ascomya fungal probiotic platform with first ingredient PK88
Biohm Technologies has launched Ascomya, a new fungal probiotic platform powered by its proprietary Symbiont AI technology, with PK88 — a novel Pichia kluyveri strain — the first ingredient in a pipeline targeting emerging opportunities in microbiome health
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Marketing
![Why full dose disclosure is about to become the price of entry for DTC supplement brands]()
Why full dose disclosure is about to become the price of entry for DTC supplement brands
For decades, supplement brands have competed in terms of how much they could fit in the blend and on the label. Johnny Meagher, founder of Proco, says the winners of the future will be those who are willing to show their work
